Lactylation in colorectal cancer: Unveiling novel mechanisms in metabolism, progression and therapeutic targeting
Clinical and Translational Medicine · 2026-02 · 16 (2)
DOI: 10.1002/ctm2.70629 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, online erschienen am 19.02.2026. Verfasst von Ming Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Province Leading Talents Cultivation Project for Traditional Chinese Medicine, Natural Science Foundation of Jiangsu Province, Medical Scientific Research Project of Jiangsu Provincial Commission of Health.
Abstract (Originalsprache)
Background Colorectal cancer is a leading cause of cancer mortality characterised by a unique metabolic microenvironment and complex interactions with the gut microbiota. Lactylation, a novel post‐translational modification derived from lactate, has emerged as a key epigenetic regulator connecting metabolic reprogramming to gene expression. While its general roles in cancer are recognised, the tissue‐specific regulatory network of lactylation in colorectal cancer—particularly its interplay with the gut microbiome and specific chemotherapy resistance mechanisms—remains underexplored. Main body This review systematically dissects the dynamic ‘writer‒eraser‒reader’ network of lactylation, highlighting its distinct oncogenic functions in colorectal cancer. We reveal a critical ‘microbiome‒metabolism‒epigenetics’ axis in which gut flora‐derived metabolites (including D‐lactate) remodel the tumour microenvironment and drive immune evasion. Beyond histone modifications, we emphasise the pivotal role of non‐histone lactylation targets (e.g., eEF1A2, PD‐L1) in orchestrating malignant proliferation and promoting liver metastasis by priming the pre‐metastatic niche. Furthermore, we elucidate novel mechanisms by which lactylation induces resistance to standard chemotherapeutic agents (5‐fluorouracil and oxaliplatin), specifically through the enhancement of DNA repair and the suppression of ferroptosis. We also critically evaluate the pharmacological challenges hindering clinical translation, such as the poor selectivity of current broad‐spectrum inhibitors. Short conclusion Lactylation serves as a fundamental metabolic‒epigenetic link driving aggressive phenotypes in colorectal cancer. By delineating these tissue‐specific mechanisms and proposing next‐generation site‐specific targeting strategies, this review provides a theoretical foundation for developing precision medicine interventions to overcome therapy resistance in colorectal cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
- The Third Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, China.
- Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China.
Förderung
- Jiangsu Province Leading Talents Cultivation Project for Traditional Chinese Medicine
- Natural Science Foundation of Jiangsu Province
- Medical Scientific Research Project of Jiangsu Provincial Commission of Health
- National Natural Science Foundation of China
- Jiangsu Clinical Innovation Center of Digestive Cancer of Traditional Chinese Medicine
Zitieren
APA
Liu, M., Li, W., Ji, Y., Chen, Y., Wei, G., Huo, J., & Gui, T. (2026). Lactylation in colorectal cancer: Unveiling novel mechanisms in metabolism, progression and therapeutic targeting. Clinical and Translational Medicine, 16(2). https://doi.org/10.1002/ctm2.70629
Vancouver
Liu M, Li W, Ji Y, Chen Y, Wei G, Huo J, et al. Lactylation in colorectal cancer: Unveiling novel mechanisms in metabolism, progression and therapeutic targeting. Clinical and Translational Medicine. 2026;16(2). doi:10.1002/ctm2.70629
BibTeX
@article{Liu2026,
author = {Liu, Ming and Li, Weiwei and Ji, Yi and Chen, Yanqing and Wei, Guoli and Huo, Jiege and Gui, Tao},
title = {Lactylation in colorectal cancer: Unveiling novel mechanisms in metabolism, progression and therapeutic targeting},
journal = {Clinical and Translational Medicine},
year = {2026},
volume = {16},
number = {2},
doi = {10.1002/ctm2.70629}
}
EUVIMED